Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05294809
Other study ID # 13.912 / 29.10.2021
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 12, 2022
Est. completion date February 2024

Study information

Verified date December 2023
Source Babes-Bolyai University
Contact Vasile Sîrbu, PhD student
Phone +40762405622
Email vasile.sirbu@ubbcluj.ro
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigating the effectiveness of two mobile psychological interventions and the mechanisms of change involved in reducing the symptoms of depression, anxiety and stress, on an adult population with a mild to moderate level of symptoms (sub-clinical).


Description:

The research design will be a 3-arm controlled clinical trial, with 4 waves of data collection. Once selected using a symptomatic screening questionnaire, participants will be randomly assigned to one of three conditions: 2 experimental conditions (PsyPills and OCAT) and an active control group (shamOCAT). Measurements will be collected before allocation (baseline), during the intervention (through a momentary ecological assessment paradigm), at the end (post) and at an interval of one month after the intervention (follow-up). Among the constructs evaluated are symptomatic level, affectivity, cognitive processes, emotional regulation and attentional bias. All measurement steps will be collected online. The interventions consist of an attentional training (Online-Contingent Attention Training, OCAT) which seeks to facilitate the disengagement from the negative content and the engagement on the positive of some personally relevant information by providing instructions and feedback on performance; and prescribing personalized rational thinking strategies to change the intensity of dysfunctional emotionality (PsyPills). The active control group consists of a "fake" version of OCAT (shamOCAT), by offering the same attentional training, without training and feedback on performance. All interventions are delivered in the form of smartphone applications.


Recruitment information / eligibility

Status Recruiting
Enrollment 430
Est. completion date February 2024
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - 18-65 years old - Have access and able to use a smartphone

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
PsyPills
Prescribing personalized rational thinking strategies to change levels of dysfunctional emotionality.
Online-Contingent Attention Training, OCAT
Facilitating the disengagement from negative content and engagement of positive one of personally relevant information by providing instruction and feedback on performance.
shamOCAT
The active control group, which consists of the "fake" version of the OCAT intervention, by offering the same attentional training, without training and feedback on performance.

Locations

Country Name City State
Romania Babes-Bolyai University Cluj-Napoca

Sponsors (2)

Lead Sponsor Collaborator
Babes-Bolyai University Universidad Complutense de Madrid

Country where clinical trial is conducted

Romania, 

Outcome

Type Measure Description Time frame Safety issue
Other Experience Sampling Methods (ESM) questionnaire Items selected from the main scales, including 8 items for rational/irrational beliefs, 9 affective state items, 5 items from the subscales of interest of CERQ-SF, on a visual analog scale (VAS) format; the direction of scores is the same with those of the original scales and subscales from which th items are taken from During the intervention (3 times daily from day 1 to day 10)
Primary Depressive, Anxiety, and Stress Symptoms DASS-21, with scores from 0 to 63, higher scores meaning worse outcomes Baseline
Primary Change from Baseline Depressive, Anxiety, and Stress Symptoms at 5 days DASS-21, with scores from 0 to 63, higher scores meaning worse outcomes Mid of intervention (5 days)
Primary Change from Baseline Depressive, Anxiety, and Stress Symptoms at 10 days DASS-21, with scores from 0 to 63, higher scores meaning worse outcomes Post intervention (10 day)
Primary Change from Baseline Depressive, Anxiety, and Stress Symptoms at 1 month DASS-21, with scores from 0 to 63, higher scores meaning worse outcomes Follow-up (1 month)
Secondary Functional Reappraisal Acceptance, Putting into perspective and inversed scores of Catastrophizing subscales of CERQ-SF, with scores from 6 to 30, higher scores meaning better outcomes Baseline
Secondary Change from Baseline Functional Reappraisal at 5 days Acceptance, Putting into perspective and inversed scores of Catastrophizing subscales of CERQ-SF, with scores from 6 to 30, higher scores meaning better outcomes Mid of intervention (5 days)
Secondary Change from Baseline Functional Reappraisal at 10 days Acceptance, Putting into perspective and inversed scores of Catastrophizing subscales of CERQ-SF, with scores from 6 to 30, higher scores meaning better outcomes Post intervention (10 day)
Secondary Change from Baseline Functional Reappraisal at 1 month Acceptance, Putting into perspective and inversed scores of Catastrophizing subscales of CERQ-SF, with scores from 6 to 30, higher scores meaning better outcomes Follow-up (1 month)
Secondary Positive Reappraisal Positive reappraisal subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning better outcomes Baseline
Secondary Change from Baseline Positive Reappraisal at 5 days Positive reappraisal subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning better outcomes Mid of intervention (5 days)
Secondary Change from Baseline Positive Reappraisal at 10 days Positive reappraisal subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning better outcomes Post intervention (10 days)
Secondary Change from Baseline Positive Reappraisal at 1 month Positive reappraisal subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning better outcomes Follow-up (1 month)
Secondary Rational and Irrational Beliefs HABS-AV, with scores from 24 to 120, with higher scores meaning worse outcomes Baseline
Secondary Change from Baseline Rational and Irrational Beliefs at 5 days HABS-AV, with scores from 24 to 120, with higher scores meaning worse outcomes Mid of intervention (5 days)
Secondary Change from Baseline Rational and Irrational Beliefs at 10 days HABS-AV, with scores from 24 to 120, with higher scores meaning worse outcomes Post intervention (10 days)
Secondary Change from Baseline Rational and Irrational Beliefs at 1 month HABS-AV, with scores from 24 to 120, with higher scores meaning worse outcomes Follow-up (1 month)
Secondary Rumination Focus on thought/rumination subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning worse outcomes Baseline
Secondary Change from Baseline Rumination at 5 days Focus on thought/rumination subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning worse outcomes Mid of intervention (5 days)
Secondary Change from Baseline Rumination at 10 days Focus on thought/rumination subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning worse outcomes Post intervention (10 days)
Secondary Change from Baseline Rumination at 1 month Focus on thought/rumination subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning worse outcomes Follow-up (1 month)
Secondary Functional and Dysfunctional Emotions PAD, functional emotions subscale, with scores from 12 to 60, and dysfunctional emotions subscale, with scores from 14 to 70, with higher scores meaning worse outcomes Baseline
Secondary Change from Baseline Functional and Dysfunctional Emotions at 5 days PAD, functional emotions subscale, with scores from 12 to 60, and dysfunctional emotions subscale, with scores from 14 to 70, with higher scores meaning worse outcomes Mid of intervention (5 days)
Secondary Change from Baseline Functional and Dysfunctional Emotions at 10 days PAD, functional emotions subscale, with scores from 12 to 60, and dysfunctional emotions subscale, with scores from 14 to 70, with higher scores meaning worse outcomes Post intervention (10 days)
Secondary Change from Baseline Functional and Dysfunctional Emotions at 1 month PAD, functional emotions subscale, with scores from 12 to 60, and dysfunctional emotions subscale, with scores from 14 to 70, with higher scores meaning worse outcomes Follow-up (1 month)
Secondary Attention bias Engagement in positive information and inhibition of negative information web measures with an index of attention bias for processing positive vs. negative material computed by dividing the total fixation time on positive words by the total fixation time on emotional (positive and negative) words Baseline
Secondary Change from Baseline Attention Bias at 5 days Engagement in positive information and inhibition of negative information web measures with an index of attention bias for processing positive vs. negative material computed by dividing the total fixation time on positive words by the total fixation time on emotional (positive and negative) words Mid of intervention (5 days)
Secondary Change from Baseline Attention Bias at 10 days Engagement in positive information and inhibition of negative information web measures with an index of attention bias for processing positive vs. negative material computed by dividing the total fixation time on positive words by the total fixation time on emotional (positive and negative) words Post intervention (10 days)
Secondary Change from Baseline Attention Bias at 1 month Engagement in positive information and inhibition of negative information web measures with an index of attention bias for processing positive vs. negative material computed by dividing the total fixation time on positive words by the total fixation time on emotional (positive and negative) words Follow-up (1 month)
See also
  Status Clinical Trial Phase
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed NCT05130944 - Feasibility of Community Psychosocial Intervention for Women N/A
Recruiting NCT05526235 - A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities N/A
Recruiting NCT05413941 - Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease N/A
Completed NCT03720600 - Forms of Racial Discrimination Study N/A
Not yet recruiting NCT05400096 - Psychological Wellbeing in Clients in Tier 3 Weight Management Service N/A
Completed NCT02212236 - Psychological Intervention for Distress During HSCT Phase 2
Active, not recruiting NCT00892138 - Mindfulness Training for Stress Management N/A
Recruiting NCT04936828 - Ecological Momentary Intervention for Stroke Caregivers' Psychological Support N/A
Recruiting NCT04815278 - NC Works4Health: Reducing Chronic Disease Risks in Socioeconomically Disadvantaged, Unemployed Populations N/A
Withdrawn NCT03341364 - Acceptance and Commitment Based Group Therapy for Cancer Patients N/A
Recruiting NCT05137925 - Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum N/A
Completed NCT04376723 - Mental Health Apps for Mild Psychological Distress Amongst Adolescents N/A
Active, not recruiting NCT04020497 - Ensemble Programme an Early Intervention for Informal Caregivers of Psychiatric Patients N/A
Terminated NCT03587896 - Implementation of Self Help Plus in Adult Syrian Refugees in Turkey (RE-DEFINE) N/A
Not yet recruiting NCT03652168 - Stress Free UC Merced: The Effect of 8 Weeks of Mindfulness App Headspace on Stress in a Sample of University Employees Phase 3
Completed NCT03721770 - Psychological Impact in a Relative, Following the Announcement of the Death of a Loved One After Cardiac Arrest and the Early Request for Organ Donation
Recruiting NCT05849454 - Messy Memories: Mobile Application Therapy Following Critical Illness N/A
Recruiting NCT05525299 - Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors N/A
Recruiting NCT06052904 - Music Breathing for Caregivers of Children Newly Diagnosed With Cancer N/A